Conference Calendar - The 33rd International Papillomavirus Conference

Times are stated in CEST (GMT + 2 / UTC + 2)
Every effort has been made to convert the IPVC 2020 scientific program into a fully virtual program. Thank you to all the presenters who have submitted their recordings in advance. These are available as on-demand webcasts in the interactive program on the virtual conference platform. Please note that some presenters were not able to pre-record their presentations, therefore there are still some sessions with missing presentations.

To view the pre-conference workshops, you need to register for them separately. Please contact: reg_ipvc20@kenes.com
You will then receive an email with instructions on how to login to the workshops’ platform.

Displaying One Session

View

Clinical Science Oral Session

00910 - Oral Session 9: Biomarkers Cervix and Other Sites (ID 80)

Session Type

Clinical Science Oral Session

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Chair(s)

Watch Stream
Session Webcast

Session Webcast

[{"name":"SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER \u003Csmall\u003E(ID 240)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":240,"presentation":"SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER \u003Csmall\u003E(ID 240)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"St\u00e8fanie Dick (Netherlands)","photo":""},"playlist":[{"name":"Evaluation of six methylation markers derived from genome-wide screens for detection of cervical pre","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/894E2D05.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Stefanie Dick IPVC20 240 SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER.vtt"}]},{"name":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3) \u003Csmall\u003E(ID 1488)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1488,"presentation":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2\/3 (CIN2\/3) \u003Csmall\u003E(ID 1488)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"C L. Trimble (United States of America)","photo":""},"playlist":[{"name":"A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/BD91BCE.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Connie Trimble - IPVC20 - 1488 - A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia.vtt"}]},{"name":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE CLASSIFIER OF CERVICAL CYTOLOGY \u003Csmall\u003E(ID 221)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":221,"presentation":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE CLASSIFIER OF CERVICAL CYTOLOGY \u003Csmall\u003E(ID 221)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Jane Shen-Gunther (United States of America)","photo":""},"playlist":[{"name":"MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/2A58D443.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/221 Jane Shen Gunther.vtt"}]},{"name":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING \u003Csmall\u003E(ID 664)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":664,"presentation":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING \u003Csmall\u003E(ID 664)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Hongsheng Lu (China)","photo":""},"playlist":[{"name":"EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/8A09285B.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Presentation 664 EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING.vtt"}]},{"name":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CANCER OF THE ANUS \u003Csmall\u003E(ID 1325)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":1325,"presentation":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CANCER OF THE ANUS \u003Csmall\u003E(ID 1325)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"Sona Chowdhury (United States of America)","photo":""},"playlist":[{"name":"PD-L1\/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CE","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/72F63426.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/Sona Chowdhury p1325 IPVC20.vtt"}]},{"name":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING PREDICTIVE AND PROGNOSTIC BIOMARKER FOR HPV-ASSOCIATED OROPHARYNGEAL CANCERS \u003Csmall\u003E(ID 242)\u003C\/small\u003E","mode":"playlist","public":true,"info":{"id":242,"presentation":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING PREDICTIVE AND PROGNOSTIC BIOMARKER FOR HPV-ASSOCIATED OROPHARYNGEAL CANCERS \u003Csmall\u003E(ID 242)\u003C\/small\u003E","session":"Oral Session 9: Biomarkers Cervix and Other Sites","presenter":"H\u00e9l\u00e8ne P\u00e9r\u00e9 (France)","photo":""},"playlist":[{"name":"PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING","source":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.mp4","source_path":"s3:\/\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.mp4","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/1A3BB6EB.jpg","data":[],"tracks":[],"chapters":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-recordings\/ipvc20\/80\/P--r-----R_.vtt"}]}]

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

SYSTEMATIC ANALYSIS OF EIGHT DNA METHYLATION MARKERS DEMONSTRATES A COMPARABLE HIGH DIAGNOSTIC PERFORMANCE FOR CIN3 AND CERVICAL CANCER (ID 240)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

12:20 - 12:32

Presenter

Stèfanie Dick (Netherlands)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

A first-in-human proof-of-concept trial of intravaginal artesunate to treat cervical intraepithelial neoplasia 2/3 (CIN2/3) (ID 1488)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

12:32 - 12:44

Presenter

C L. Trimble (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

MOLECULAR PAP SMEAR: EXTERNAL VALIDATION OF HPV GENOTYPE AND HOST EPIGENETIC MARKERS AS A PREDICTIVE CLASSIFIER OF CERVICAL CYTOLOGY (ID 221)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

12:44 - 12:56

Presenter

Jane Shen-Gunther (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

EVALUATION OF TWO HYBRID CAPTURE BASED HPV ASSAY WITH HPV16 AND HPV18 GENOTYPING (ID 664)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

12:56 - 13:08

Presenter

Hongsheng Lu (China)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

PD-L1/PD-1 EXPRESSION PATTERN IN NORMAL, HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESIONS AND SQUAMOUS CELL CANCER OF THE ANUS (ID 1325)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

13:08 - 13:20

Presenter

Sona Chowdhury (United States of America)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

COMPARISON OF NEXT GENERATION SEQUENCING AND REAL-TIME PCR FOR THE EARLIER DETECTION OF HPV+ OROPHARYNGEAL HEAD AND NECK CANCER (ID 873)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

13:20 - 13:32

Presenter

Austin Mattox (United States of America)

Authors

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

PRE-THERAPEUTIC HPV CIRCULATING TUMORAL DNA QUANTIFICATION BY DROPLET-BASED DIGITAL PCR: A PROMISING PREDICTIVE AND PROGNOSTIC BIOMARKER FOR HPV-ASSOCIATED OROPHARYNGEAL CANCERS (ID 242)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

13:32 - 13:44

Presenter

Hélène Péré (France)

Authors

Webcast

Webcast

[session]

[presentation]

[presenter]

Hide

Oral Session 9: Biomarkers Cervix and Other Sites Hall C

Online Chat Q&A for this session is called: CLINICAL SCIENCE ORAL SESSION 9: BIOMARKERS CERVIX AND OTHER SITES. You can join the online chat Q&A and discussions for this session by going back to the Lobby and entering the Networking Lounge. Speakers are encouraged to be online in the chat room at the time this session is stated to end. All times are in CEST. (ID 1791)

Session Date

07/23/2020

Session Time

12:20 - 13:45

Room

Hall C

Session Type

Clinical Science Oral Session

Session Name

Oral Session 9: Biomarkers Cervix and Other Sites

Lecture Time

13:44 - 13:44